1. Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol. 2004. 50:391–404.
2. Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol. 2003. 112:S128–S139.
![crossref](/image/icon/bnr_ref_cross.gif)
3. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006. 118:152–169.
![crossref](/image/icon/bnr_ref_cross.gif)
4. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol. 1998. 102:558–562.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Pipet A, Botturi K, Pinot D, Vervloet D, Magnan A. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy. Respir Med. 2009. 103:800–812.
![crossref](/image/icon/bnr_ref_cross.gif)
6. Novak N. Allergen specific immunotherapy for atopic dermatitis. Curr Opin Allergy Clin Immunol. 2007. 7:542–546.
![crossref](/image/icon/bnr_ref_cross.gif)
7. Werfel T, Breuer K, Ruéff F, Przybilla B, Worm M, Grewe M, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy. 2006. 61:202–205.
![crossref](/image/icon/bnr_ref_cross.gif)
8. Nahm DH, Lee ES, Park HJ, Kim HA, Choi GS, Jeon SY. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex. Int Arch Allergy Immunol. 2008. 146:235–240.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980. 92:Suppl. 44–47.
10. Oranje AP, Glazenburg EJ, Wolkerstorfer A, de Waard-van der Spek FB. Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. Br J Dermatol. 2007. 157:645–648.
![crossref](/image/icon/bnr_ref_cross.gif)
11. Kim ME, Kim JE, Sung JM, Lee JW, Choi GS, Nahm DH. Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis. J Korean Med Sci. 2011. 26:1159–1164.
![crossref](/image/icon/bnr_ref_cross.gif)
12. BuBmann C, Bieber T, Novak N. Systemic therapeutic options for severe atopic dermatitis. J Dtsch Dermatol Ges. 2009. 7:205–219.
![crossref](/image/icon/bnr_ref_cross.gif)
13. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2000. CD001186.
![crossref](/image/icon/bnr_ref_cross.gif)
14. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev. 2007. CD001936.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Czarnecka-Operacz M, Silny W. Specific immunotherapy in atopic dermatitis--Four-year treatment in different age and airborne allergy type subgroups. Acta Dermatovenerol Croat. 2006. 14:230–240.
16. Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2007. 21:606–619.
![crossref](/image/icon/bnr_ref_cross.gif)
17. Kroot EJ, Huisman AM, Van Zeben J, Wouters JM, Van Paassen HC. Oral pulsed dexamethasone therapy in early rheumatoid arthritis: a pilot study. Ann N Y Acad Sci. 2006. 1069:300–306.
![crossref](/image/icon/bnr_ref_cross.gif)
18. Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol. 2011. 127:18–27.
![crossref](/image/icon/bnr_ref_cross.gif)
19. Krathen RA, Hsu S. Failure of omalizumab for treatment of severe adult atopic dermatitis. J Am Acad Dermatol. 2005. 53:338–340.
![crossref](/image/icon/bnr_ref_cross.gif)
20. Takiguchi R, Tofte S, Simpson B, Harper E, Blauvelt A, Hanifin J, et al. Efalizumab for severe atopic dermatitis: a pilot study in adults. J Am Acad Dermatol. 2007. 56:222–227.
![crossref](/image/icon/bnr_ref_cross.gif)
21. Simon D, Hösli S, Kostylina G, Yawalkar N, Simon HU. Anti-CD20 (rituximab) treatment improves atopic eczema. J Allergy Clin Immunol. 2008. 121:122–128.
![crossref](/image/icon/bnr_ref_cross.gif)